Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel by Hakan Taban, Mustafa Erman, Deniz Can Guven, Burak Yasin Aktas, Feride Yilmaz, Serkan Yaşar, Hasan Cagri Yildirim, Ferit Aslan, Sercan Aksoy

Get full text

Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study by Furkan Ceylan, Selin Aktürk Esen, Olçun Ümit Ünal, Ferit Aslan, İlknur Deliktaş Onur, Öztürk Ateş, Erkut Demirciler, İlkay Tuğba Ünek, Ahmet Gülmez, Esra Özen Engin, Semra Taş, Gamze Gököz Doğu, Melih Şimşek, Hacı Mehmet Türk, Ali İnal, Gökhan Şahin, Haydar Çağatay Yüksel, Ateş Kutay Tenekeci, Mutlu Hızal, Mehmet Ali Nahit Şendur, Doğan Uncu

Get full text

Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study by Serhat Sekmek, Sema Nur Ozsan Çelebi, Dogan Bayram, Cihan Erol, Fahriye Tugba Kos, Mehmet Ali Nahit Sendur, Yunus Emre Altıntas, Tugba Tuylu, Sedat Yildirim, Sedat Biter, Mehmet Mutlu Kıdı, Ertugrul Bayram, Nargiz Majidova, Ibrahim Vedat Bayoglu, Mehmetcan Atak, Kadriye Baskurt, Sinem Akbas, Ali Alkan, Ayberk Bayramgil, Ferit Aslan, Elif Sahin, Onur Yazdan Balcik, Ahmet Ziya Bayhan, Seray Saray, Erkan Arpaci, Yakup Ergun

Get full text